Posted Oct. 2, 2012 at 6:29 a.m.

Premium Lock Pozen prevails in patent fight over pain killer

Published: 2012-10-02 06:29:31
Updated: 2012-10-02 06:29:31

Treixmet Treximet

The Chapel Hill-based pharmaceutical firm has already sold future royalty rights and milestone payments that it would have received from GlaxoSmithKline for $75 million....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2015 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders